BR in Patients With CLL With Comorbidities and/or Renal Dysfunction
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Small Lymphocytic Lymphoma
Related studies linked through entity extraction aliases.
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- Status
- RECRUITING
- Phase
- PHASE3
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLL
- Status
- COMPLETED
- Phase
- PHASE2
Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLL
- Status
- TERMINATED
- Phase
- PHASE1
Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Open-label Phase 3 BTK Inhibitor Ibrutinib vs Chlorambucil Patients 65 Years or Older With Treatment-naive CLL or SLL
- Status
- COMPLETED
- Phase
- PHASE3
Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
- Status
- COMPLETED
- Phase
- PHASE2
Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL
- Status
- COMPLETED
- Phase
- PHASE2
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
- Status
- COMPLETED
- Phase
- PHASE1
R-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL
- Status
- COMPLETED
- Phase
- PHASE1
Unrelated Donor Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA